Scott Terrillion, Sec'y, Chief Compliance & G.C at Cara Therapeutics, Inc. (CARA), sold 6,180 shares at $17.98 ($111K) on 2021-03-05, disclosed to the SEC on 2021-03-08.
Open-market sale of $111k CARA by Sec'y, Chief Compliance & G.C. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.98 | 3,090 | $56K | 50.0% |
| 2 | $17.98 | 3,090 | $56K | 50.0% |
| Total | $17.98 avg | 6,180 | $111K | 100% |
| Filing → |
| CARA | SELL | 2024-03-04 | $3K | — | Filing → |
| CARA | SELL | 2024-02-12 | $4K | — | Filing → |
| CARA | SELL | 2023-06-27 | $9K | — | Filing → |